2012 | |
---|---|
Criterium: | Position: |
Overall Score: | 900-1000 |
Networking Rank (Reputation): | 900-1000 |
Networking Rank (Reputation): | 900-1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2012 | 0 | 17.975.940 | 1.148.398 | 3 |
Total number of partners: 44
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 44
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2012-12-01 | Adoptive engineered T cell Trials to Achieve Cancer Killing | ATTACK | participant | 6.000.000 | 16 |
2012-11-01 | "Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD)" | TARGETAMD | participant | 5.976.298 | 15 |
2012-10-01 | Rational molecular Assessments and Innovative Drug Selection | RAIDS | participant | 5.999.642 | 16 |